Results 141 to 150 of about 370,070 (295)

Cutaneous Hodgkin’s lymphoma

South Asian Journal of Cancer, 2017
Asawari Anant Ambekar, Chitralekha S Soman   +1 more
openaire   +3 more sources

Ropeginterferon‐α2b in mycosis fungoides and Sézary syndrome: Safety and efficacy in 41 patients

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Pegylated interferon‐α2a became the off‐label alternative for treating mycosis fungoides/Sézary syndrome (MF/SS) after non‐pegylated interferons were withdrawn. This study aimed to evaluate the safety and efficacy of ropeginterferon‐α2b in MF/SS. Patients and methods We performed a retrospective multicenter analysis at
Stefanie Porkert, Juliette M. Kersten, Rosanne Ottevanger, Hanna Schratter, Regina Fink‐Puches, Van Anh Nguyen, Farzaneh Sadeghyar, Johanna Latzka, Franz Trautinger, Magdalena Hoellwerth, Peter Koelblinger, Nicole Pfannschmidt, Nina Haering, Johannes Griss, Maarten H. Vermeer, Constanze Jonak   +15 more
wiley   +1 more source

Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry. [PDF]

J Eur Acad Dermatol Venereol, 2021
Sánchez-Velázquez A, Bauer-Alonso A, Estrach T, Vega-Díez D, Garcia-Muret P, Haya L, Peñate Y, Acebo E, Fernández de Misa R, Blanes M, Suh-Oh HJ, Izu R, Silva-Díaz E, Sarriugarte J, Román-Curto C, Botella-Estrada R, Mateu-Puchades A, Prieto-Torres L, Morillas V, Morillo M, Sánchez-Caminero P, Calzado L, Pérez-Ferriols A, Pérez A, Domínguez JD, Navedo M, Muniesa C, Combalia A, Arroyo-Andrés J, Descalzo MA, García-Doval I, Ortiz-Romero PL.   +31 more
europepmc   +1 more source

Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel

, 2019
Daphné Denis,1 Nathalie Beneton,1 Kamel Laribi,2 Hervé Maillard1 1Dermatology Department, Centre Hospitalier Le Mans, Le Mans, France; 2Haematology Department, Centre Hospitalier Le Mans, Le Mans, France Abstract: Mycosis fungoides (MF) is ...
Denis D, Laribi K, Beneton N, Maillard H
core  

A case of secondary syphilis masquerading as cutaneous lymphoma. [PDF]

JAAD Case Rep, 2021
Nethers K, Mojica RE, Marks E, Burger R, Saeed S, Steffes W.   +5 more
europepmc   +1 more source

Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis

European Journal of Haematology, EarlyView.
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley   +1 more source

Cutaneous manifestations as the presenting signs of diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements

JAAD Case Reports
Gabriela Piñero-Crespo, BS, Alison H. Kucharik, MD, Wei-Shen Chen, MD, PhD, Dietrich Werner Idiáquez, MD, Josef Doenges, MD, Yumeng Zhang, MD, Lubomir Sokol, MD, PhD, Frank Glass, MD   +7 more
doaj   +1 more source

Cutaneous lymphoma : diagnosis and treatment

Drs. John C. Hall and Brian J. Hall have assembled world leaders on this ever-changing topic of Cutaneous Lymphoma and to explore the advancements in research. The text first discusses the new classifications of cutaneous lymphoma.
Hall, John C.
core  

Cutaneous T-cell lymphoma

, 2005
Phenotype / cell stem origin These are peripheral T-cell tumours, usually expressing CD4 along with other T-cell markers. The CD30 molecule is expressed in a histologically distinct subset (vide infra).
CASTOLDI G.L., CUNEO, Antonio
core  

Primary cutaneous lymphoma and risk for severe COVID-19: a prospective study of 48 cases in Morocco. [PDF]

J Eur Acad Dermatol Venereol, 2022
Kerrouch H, Khalidi M, Frikh R, Hjira N, Boui M.   +4 more
europepmc   +1 more source